CAC
COEPW

Cowen and Company’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Cowen and Company’s Portfolio COEPW Stock Details COEPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-45,600
Closed -$684 – 81
2024
Q3 		$684 Buy
45,600
+100
+0.2% +$2 ﹤0.01% 605
2024
Q2 		$1.36K Hold
45,500
– – ﹤0.01% 590
2024
Q1 		$1.16K Buy
45,500
+100
+0.2% +$4 ﹤0.01% 646
2023
Q4 		$1.41K Buy
+45,400
New +$1.78K ﹤0.01% 544
2021
Q4 		– Sell
-79,294
Closed -$21K – 661
2021
Q3 		$21K Hold
79,294
– – ﹤0.01% 480
2021
Q2 		$43K Buy
79,294
+619
+0.8% +$315 ﹤0.01% 422
2021
Q1 		$34K Buy
+78,675
New +$73.8K ﹤0.01% 419

Other funds holding COEPW

MC
Meteora Capital Boca Raton, Florida $1.36B AUM 20.06% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
HHGC
Hunting Hill Global Capital New York $129M AUM 17.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cowen and Company's COEPW Position: Q4 2024 in Review

Cowen and Company sold out of Coeptis Therapeutics Warrants (COEPW) in Q4 2024, closing a stake of 45,600 shares — an estimated $684 sold.

Cowen and Company first reported a position in COEPW in Q1 2021 and held it in 7 quarters. The position peaked at $43K in Q2 2021. 13 funds tracked by Wall St. Rank hold COEPW as of Q4 2024.

  • Cowen and Company reported no remaining Coeptis Therapeutics Warrants position as of Q4 2024 after selling out during the quarter.
  • Cowen and Company sold 45,600 Coeptis Therapeutics Warrants shares in Q4 2024, an estimated $684.
  • Cowen and Company first reported a position in Coeptis Therapeutics Warrants in Q1 2021 and held it in 7 quarters.
  • Cowen and Company's Coeptis Therapeutics Warrants position peaked at $43K in Q2 2021.
  • 13 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q4 2024.

Based on Cowen and Company's 13F filing for Q4 2024.